S09 Nuclear Receptor Control of Health and Disease

Program: Symposia
Basic/Translational Session
Friday, April 1, 2016: 9:45 AM-11:15 AM
Room 104 (BCEC)
Chair:
Kenneth S Korach, PhD, National Institute of Environmental Health Sciences/NIH, Research Triangle Park, NC

Nothing to Disclose: KSK
9:45 AM
Ira Glenn Schulman, PhD, University of Virginia, Charlottesville, VA
Nothing to Disclose: IGS
10:15 AM
Yukitomo Arao, PhD, Reproductive and Developmental Biology, National Institute of Environmental Health Sciences/NIH, Research Triangle Park, NC
Nothing to Disclose: YA
10:30 AM
C.Daniel De Magalhaes Filho, PhD, Evans Laboratory, The Salk Institute for Biological Studies, La Jolla, CA
Nothing to Disclose: CDD
10:45 AM
George E.O. Muscat, PhD, The Univ of QLD, St Lucia QLD, Australia
Nothing to Disclose: GEOM
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire